Compulsory licensing for Sars-cov-2 – Covid 19 vaccines in Brazil and legal support under the WTO TRIPS agreement
Palabras clave:
Compulsory Licensing, Vaccines, TRIPS Agreement, PatentResumen
The debate about compulsory licensing “patent breaking” in the case of a Pandemic arose from the need to vaccinate the Brazilian population in a short space of time, however, the pharmaceutical companies holding the patents did not have the capacity to deliver the product, since their production lines, we are not prepared for such productive speed, given that the entire planet was looking for the same product, in order to save lives, immunizing their populations where the present study has as its object, to analyze the legal support, if the country come to enact the compulsory licensing of a vaccine against (Sars-Cov2) Covid 19, what will be the impacts on the Industrial Property Agreement (Trips) of the World Trade Organization (WTO), the technical feasibility, and the diplomatic considerations of the action. And to achieve these objectives, the bibliographic research methodology with a qualitative approach was used, in order to elucidate how to meet the country's demand for the acquisition of vaccines to immunize the entire population in times of pandemic.
